Screener
Acadia Pharmaceuticals ACAD Net Income
Net Income at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Acadia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:ProfitLoss.
The source filing: Acadia Pharmaceuticals’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 4, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333243
FAQ
- What is Acadia Pharmaceuticals's net income?
- Acadia Pharmaceuticals (ACAD) reported net income of $31.5M in Q2 2026.
- How has Acadia Pharmaceuticals's net income changed year-over-year?
- Acadia Pharmaceuticals's net income increased by 18.1% year-over-year, from $26.67M to $31.5M.
- What is the long-term trend for Acadia Pharmaceuticals's net income?
- Over 4 years (2021 to 2025), Acadia Pharmaceuticals's net income has grown at a 23.5% compound annual growth rate (CAGR), from -$167.87M to $391M.
- What does net income mean?
- Net income as the starting point for the indirect method operating cash flow reconciliation.
Ask your AI about Acadia Pharmaceuticals's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude